Profile data is unavailable for this security.

About the company

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

  • Revenue in USD (TTM)51.47bn
  • Net income in USD-8.63bn
  • Incorporated--
  • Employees101.17k
  • Location
    Bayer AGKaiser-Wilhelm-Allee 1LEVERKUSEN 51373GermanyDEU
  • Phone+49 214301
  • Fax+49 2 143066328
  • Websitehttps://www.bayer.de/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BAYX.N:GER since
Noho Health IncAnnounced31 Aug 202031 Aug 2020Announced3.98%--
Data delayed at least 15 minutes, as of Sep 18 2020 16:35 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Shanghai Fosun Pharmaceutical (Group)4.20bn520.03m16.47bn31.37k34.933.70--3.921.371.3711.1312.890.36973.025.99906,616.104.986.087.609.1056.4057.0313.4816.560.7985--0.381430.1914.7218.9122.669.4728.766.85
Shionogi & Co Ltd3.10bn1.12bn17.49bn5.22k15.482.3214.145.64379.11379.111,050.772,528.890.40021.385.4462,044,240.0014.4014.0115.7715.8382.8480.0135.9830.576.43--0.014925.13-9.404.00-10.9322.63-2.5314.65
Merck KGaA20.04bn1.68bn19.39bn57.52k38.803.134.840.96793.273.2438.9341.360.40591.964.79296,724.903.414.194.535.5561.9965.058.4010.490.6146.270.438710.238.877.2920.632.2310.345.39
Otsuka Holdings Co Ltd13.59bn1.40bn23.89bn32.99k17.021.3410.971.76263.09263.092,619.583,331.030.54722.583.8243,057,410.005.764.236.995.2068.3266.8110.527.991.91--0.113452.458.07--54.14------
Alexion Pharmaceuticals, Inc.5.54bn846.10m24.92bn3.08k30.472.3820.634.503.733.7324.8647.880.35410.86944.441,796,496.005.415.345.815.7591.5890.6615.2818.834.28--0.18860.0020.8117.4411,294.7929.634.55--
Astellas Pharma Inc12.18bn1.79bn28.96bn15.88k16.282.3111.892.3899.9099.90680.98703.500.6091.743.5480,191,270.008.9610.5612.2014.0579.1376.9514.7115.090.9896--0.253636.12-0.42140.8448-12.087.54-0.82115.92
Takeda Pharmaceutical Co Ltd31.02bn1.15bn60.14bn47.50k52.151.339.401.9476.4976.492,073.522,998.370.2481.254.2068,300,180.000.91561.631.082.0768.0668.863.695.280.84441.310.5197164.4456.9313.11-67.28--14.900.00
Bayer AG (ADR)51.47bn-8.63bn66.60bn101.17k--1.58--1.29-2.20-1.6913.1110.750.34511.703.18495,704.40-5.773.25-7.664.1060.2360.77-16.717.560.61915.160.535382.9118.521.0575.47-
Chugai Pharmaceutical Co Ltd7.02bn1.82bn75.65bn7.39k40.668.55--10.78115.87115.87446.25551.130.71311.593.6499,272,250.0018.5210.3421.6912.2563.2354.4525.9715.803.69--0.0049.7618.358.2770.3625.3226.1323.87
Data as of Sep 18 2020. Currency figures normalised to Bayer AG's reporting currency: US Dollar USD

Institutional shareholders

0.17%Per cent of shares held by top holders
HolderShares% Held
Parametric Portfolio Associates LLCas of 30 Jun 20202.32m0.06%
BlackRock Investment Management LLCas of 30 Jun 20201.95m0.05%
Academy Capital Management, Inc.as of 30 Jun 2020970.27k0.03%
Equitable Investment Management Group LLCas of 30 Jun 2020518.52k0.01%
Horizon Investments LLCas of 31 May 2020207.83k0.01%
Meritage Portfolio Management, Inc.as of 30 Jun 2020173.95k0.00%
Jolley Asset Management LLCas of 31 Mar 2020160.94k0.00%
Teachers Retirement System of the State of Kentuckyas of 30 Jun 2020151.70k0.00%
Todd Asset Management LLCas of 30 Jun 2020151.70k0.00%
Ally Financial, Inc. (Investment Management)as of 30 Jun 2020120.00k0.00%
More ▼
Data from 31 Mar 2020 - 30 Jun 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.